Q&A on Nanotech regulation in Europe

Chemistry World posted a good article yesterday on nanotech regulation in Europe (Europe mulls best way to handle nanotech by Andrew Williams).  I have a couple of quotes in the piece, along with Risk Science Center colleague Diana Bowman).  These are taken from a...

The antibiotics challenge

Neil Hawkins at Dow Chemical tweeted me a link to this piece in the New York Times this morning: A Dearth in Innovation for Key Drugs (Eduardo Porter) There is clearly something wrong with pharmaceutical innovation. Antibiotic-resistant infections sicken more than two...

When risk gets personal

When you’re facing a life or death situation, what do the odds mean – to you personally?  As Brian Zikmund-Fisher from the University of Michigan School of Public Health pointed out to Robert Siegel on NPR yesterday, “We’re never 95 percent...